Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

Fda Be Nimble, Fda Be Quick


Washington Outlook: CAPITAL WRAPUP

FDA BE NIMBLE, FDA BE QUICK

Congress is finally moving to reform the Food & Drug Administration--cautiously. Senator Nancy L. Kassebaum (R-Kan.) is circulating a bill that would speed up FDA reviews of drugs and medical devices. One proposed change: allowing product approvals after one major clinical trial, instead of the current two. GOP hard-liners and some industry execs favor more radical deregulation. But companies are pleased that even modest FDA reform is under way at last.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus